Clinical Trial Update: Effects of Bisphosphonates on OI-Related Hearing Loss [Phase 4]

View source ↗

Summary

Phase 4 clinical trial is evaluating the effects of bisphosphonates on hearing loss associated with Osteogenesis Imperfecta and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Bisphosphonates (bisphosphonate)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Osteogenesis Imperfecta | Phase 4 | Status: RECRUITING